Patent application number | Description | Published |
20090062345 | AMIDE DERIVATIVES AS TRPV1 ANTAGONISTS - The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts, prodrugs, salts of prodrugs, or combinations thereof, | 03-05-2009 |
20090124666 | TRPV1 ANTAGONISTS - Compounds of formula (I) | 05-14-2009 |
20090176883 | TRPA1 Antagonists - Compounds of formula (I) | 07-09-2009 |
20090203690 | 5-SUBSTITUTED INDAZOLES AS KINASE INHIBITORS - The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, | 08-13-2009 |
20090258907 | COMPOUNDS USEFUL AS INHIBITORS OF ROCK KINASES - Disclosed herein are compounds of formula (I) or pharmaceutical acceptable salts thereof, | 10-15-2009 |
20090264480 | TRPA1 ANTAGONISTS - Compounds of formula (I) | 10-22-2009 |
20100035919 | COMPOUNDS USEFUL AS INHIBITORS OF PROTEIN KINASES - Disclosed herein are compounds of formula (I) or pharmaceutical acceptable salts thereof, | 02-11-2010 |
20100273828 | 4-(4-PYRIDINYL)-BENZAMIDES AND THEIR USE AS ROCK ACTIVITY MODULATORS - The present invention relates to novel 4-(4-pyridyl)-benzamides of the formula (I). The compounds I possess valuable therapeutic properties and are suitable, in particular, for treating diseases that respond to modulation of Rho kinases (ROCKs). R | 10-28-2010 |
20110275630 | ISOINDOLINONE KINASE INHIBITORS - Compounds having the formula: | 11-10-2011 |
20110288129 | AMIDE DERIVATIVES AS TRPV1 ANTAGONISTS - The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts, prodrugs, salts of prodrugs, or combinations thereof, | 11-24-2011 |
20120122842 | NAMPT AND ROCK INHIBITORS - Disclosed are compounds which inhibit the activity of NAMPT, compositions containing the compounds and methods of treating diseases during which NAMPT is expressed. Disclosed are compounds which inhibit the activity of ROCK, compositions containing the compounds and methods of treating diseases during which ROCK is expressed. | 05-17-2012 |
20120122846 | FURO[3,2-d]PYRIMIDINE COMPOUNDS - The present invention is directed to novel compounds of Formula (I) | 05-17-2012 |
20120190681 | PICOLINAMIDE INHIBITORS OF KINASES - The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, | 07-26-2012 |
20120330012 | Novel Tricyclic Compounds - The invention provides compounds of Formula (I) | 12-27-2012 |
20130310378 | 4-(4-PYRIDINYL)-BENZAMIDES AND THEIR USE AS ROCK ACTIVITY MODULATORS - The present invention relates to novel 4-(4-pyridyl)-benzamides of the formula (I). The compounds I possess valuable therapeutic properties and are suitable, in particular, for treating diseases that respond to modulation of Rho kinases (ROCKs). R | 11-21-2013 |
20140155389 | BICYCLIC INHIBITORS OF ALK - The present invention relates to compounds of formula (1) or pharmaceutical acceptable salts, wherein R | 06-05-2014 |
20140171429 | BICYCLIC INHIBITORS OF ALK - The present invention relates to compounds of formula (1) or pharmaceutical acceptable salts, Formula (1) wherein R | 06-19-2014 |
20140194418 | BICYCLIC CARBOXAMIDE INHIBITORS OF KINASES - Compounds of formula (I) or pharmaceutical acceptable salts are provided, wherein X | 07-10-2014 |
20140275086 | PYRROLIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY - The present invention relates to pyrrolidine derivatives of the formula (I), | 09-18-2014 |
20140275087 | PYRROLIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY - The present invention relates to pyrrolidine derivatives of the formula (I), | 09-18-2014 |
20140343066 | 5-SUBSTITUTED INDAZOLES AS KINASE INHIBITORS - The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, | 11-20-2014 |
20150025095 | Diaminopyrimidines And Uses Thereof - This disclosure relates to: (a) compounds and salts thereof that, inter alia, inhibit RSV infection and/or replication; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions. | 01-22-2015 |
20150065538 | TRPA1 ANTAGONISTS - Compounds of formula (I) | 03-05-2015 |